Search results
Results from the WOW.Com Content Network
Low-dose inhaled corticosteroids and formoterol maintenance therapy; Step 4: Daily symptoms, or waking with asthma once a week or more, and low lung function . Medium dose inhaled corticosteroids and formoterol maintenance therapy; Short-course oral corticosteroids when required in severely uncontrolled asthma
Download as PDF; Printable version; ... or insufficient or inappropriate medication use. [115] Brittle asthma is a kind ... Long-term use of inhaled corticosteroids ...
There were no asthma-related deaths and few asthma-related serious adverse events when salmeterol is used with an inhaled steroid. [ 5 ] [ 6 ] At least with formoterol , an increased risk appears to be present even when steroids are used [ 7 ] and this risk has not been ruled out for salmeterol.
Anti-asthmatic agents, also known as anti-asthma drugs, refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and ...
ATC code R03 Drugs for obstructive airway diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] [3] Subgroup R03 is part of the anatomical group R ...
Budesonide, sold under the brand name Pulmicort, among others, is a steroid medication. [8] It is available as an inhaler, nebulization solution, pill, nasal spray, and rectal forms. [8] [9] The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD).
Corticosteroids are generally indicated for moderate cases. In severe cases, adrenaline is used to reduce swelling and aid breathing. Allergen immunotherapy is an alternative treatment considered in some patients, with a success rate of 80%-90% in reducing symptoms , [ 3 ] but requiring a much longer duration of therapy.
Pulmonary drug delivery is mainly utilized for topical applications in the lungs, such as the use of inhaled beta-agonists, corticosteroids and anticholinergic agents for the treatment of asthma and COPD, the use of inhaled mucolytics and antibiotics for the treatment of cystic fibrosis (CT) and respiratory viral infections, [1] and the use of inhaled prostacyclin analogs for the treatment of ...